141 - 150 out of 368Page size: 10
  1. 2020

  2. Further exploration of DVD-445 as a lead thioredoxin reductase (TrxR) inhibitor for cancer therapy: Optimization of potency and evaluation of anticancer potential

    Jovanović, M., Zhukovsky, D., Podolski-Renić, A., Žalubovskis, R., Dar'in, D., Sharoyko, V., Tennikova, T., Pešić, M. & Krasavin, M., 1 Apr 2020, In: European Journal of Medicinal Chemistry. 191, 11 p., 112119.

    Research output: Contribution to journal › Article › peer-review

  3. α-Diazoacetamides in Sc(OTf) 3 -Catalyzed Tiffeneau-Demjanov Ring Expansion: Application towards the Synthesis of Rare Bicyclic Pyrazoles

    Chuprun, S., Dar'In, D., Kantin, G., Zhmurov, P. & Krasavin, M., 3 Mar 2020, In: Synlett. 31, 4, p. 373-377 5 p., st-2019-b0609-l.

    Research output: Contribution to journal › Article › peer-review

  4. Zn(OTf)2-catalyzed arenehydrazination of protected propargylamines leading to 3-amidoindoles

    Vedekhina, T., Lukin, A., Rogacheva, E., Kraeva, L. & Krasavin, M., 30 Jan 2020, In: Tetrahedron Letters. 61, 5, 3 p., 151430.

    Research output: Contribution to journal › Article › peer-review

  5. Unexpected outcome of the Zn(OTf)2-catalyzed arylhydrazination of alkanoyl propargylamines: Rapid entry into 1-(arylamino)imidazoles

    Vedekhina, T., Lukin, A. & Krasavin, M., 2 Jan 2020, In: Tetrahedron Letters. 61, 1, 4 p., 151365.

    Research output: Contribution to journal › Article › peer-review

  6. Aryl derivatives of 3H-1,2-benzoxathiepine 2,2-dioxide as carbonic anhydrase inhibitors

    Pustenko, A., Nocentini, A., Balašova, A., Alafeefy, A., Krasavin, M., Žalubovskis, R. & Supuran, C. T., 1 Jan 2020, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 35, 1, p. 245-254 10 p.

    Research output: Contribution to journal › Article › peer-review

  7. Further validation of strecker-type α-aminonitriles as a new class of potent human carbonic anhydrase II inhibitors: hit expansion within the public domain using differential scanning fluorimetry leads to chemotype refinement

    Krasavin, M., Kalinin, S., Zozulya, S., Griniukova, A., Borysko, P., Angeli, A. & Supuran, C. T., 1 Jan 2020, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 35, 1, p. 165-171 7 p.

    Research output: Contribution to journal › Article › peer-review

  8. Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents

    Krasavin, M., Kalinin, S., Sharonova, T. & Supuran, C. T., 1 Jan 2020, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 35, 1, p. 1555-1561 7 p.

    Research output: Contribution to journal › Article › peer-review

  9. Screening of benzenesulfonamide in combination with chemically diverse fragments against carbonic anhydrase by differential scanning fluorimetry

    Krasavin, M., Kalinin, S., Zozulya, S., Gryniukova, A., Borysko, P., Angeli, A. & Supuran, C. T., 1 Jan 2020, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 35, 1, p. 306-310 5 p.

    Research output: Contribution to journal › Article › peer-review

  10. Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms IX/XII and of human thioredoxin reductase

    Krasavin, M., Žalubovskis, R., Grandāne, A., Domračeva, I., Zhmurov, P. & Supuran, C. T., 1 Jan 2020, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 35, 1, p. 506-510 5 p.

    Research output: Contribution to journal › Article › peer-review

  11. Combining carbonic anhydrase and thioredoxin reductase inhibitory motifs within a single molecule dramatically increases its cytotoxicity

    Krasavin, M., Sharonova, T., Sharoyko, V., Zhukovsky, D., Kalinin, S., Žalubovskis, R., Tennikova, T. & Supuran, C. T., 2020, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 35, 1, p. 665-671 7 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1...11 12 13 14 15 16 17 18 ...37 Next

ID: 164751